Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)

Market Cap	2.45B -21.8%
Revenue (ttm)	569.77M -6.8%
Net Income	53.51M -36.4%
EPS	1.19 -36.0%
Shares Out	44.93M
PE Ratio	45.80
Forward PE	n/a
Dividend	1.75 (3.18%)
Ex-Dividend Date	Jun 26, 2025

Volume	16,246
Average Volume	21,404
Open	55.00
Previous Close	55.00
Day's Range	54.20 - 55.00
52-Week Range	53.00 - 80.40
Beta	-0.14
RSI	36.87
Earnings Date	Mar 30, 2026

About TPEX:4747

Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials and products in Taiwan. The company manufactures drugs in a variety of forms, such as solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. It offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamins, anti-inflammatory, cough and cold, pain reliever, etc. The company was founded in 1959 and is...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1959
• Employees: 199
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4747

Financial Performance

In 2025, TPEX:4747's revenue was 569.77 million, a decrease of -6.81% compared to the previous year's 611.42 million. Earnings were 53.51 million, a decrease of -36.40%.